(Q34948869)

5 August 2017

1 reference

title

Caffeine: neuroprotective functions in cognition and Alzheimer's disease (English)

1 reference

5 August 2017

0 references

1

Andi Rosso

1 reference

5 August 2017

Jana Mossey

2

1 reference

5 August 2017

Carol F Lippa

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

American Journal of Alzheimer's Disease & Other Dementias

5 August 2017

published in

1 reference

5 August 2017

volume

23

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

417-422

1 reference

The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

The effects of methylmercury on motor activity are sex- and age-dependent, and modulated by genetic deletion of adenosine receptors and caffeine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

The neuroprotective effects of caffeine: a prospective population study (the Three City Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Does caffeine intake enhance absolute levels of cognitive performance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Coffee consumption and cognitive function among older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Does caffeine intake protect from Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

The effects of habitual caffeine use on cognitive change: a longitudinal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Adenosine receptors in the nervous system: pathophysiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Functions of neuronal adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Adenosine receptor ligands: differences with acute versus chronic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Inhibition of acetylcholinesterase by caffeine, anabasine, methyl pyrrolidine and their derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

The influences of age and caffeine on psychomotor and cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Caffeine attenuates scopolamine-induced memory impairment in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508320083

21 January 2018

Identifiers

DOI

10.1177/1533317508320083

1 reference

5 August 2017

1 reference